Sperm must undergo capacitation to become fertilization competent. Here we validated that monosialotetrahexosylganglioside (G M1 ) localization patterns, which were assessed in the CapScore™ Sperm Function Test, reflect a capacitated state in human sperm. First, we defined patterns representing sperm that do or do not respond to stimuli for capacitation. Sperm with "capacitated" patterns had exposed acrosomal carbohydrates and underwent acrosome exocytosis in response to calcium ionophore (A23187). Precision was evaluated by percent change of the Cap-Score measured for 50, 100, 150, and 200 sperm. Changes of 11%, 6%, and 5% were observed (n ≥ 23); therefore, we counted ≥150 sperm per condition. Variance within and between readers was evaluated using 20 stitched image files generated from unique 
2012). Traditional semen analysis does not test for sperm function and,
as such, cannot report on the ability of sperm in that semen sample to fertilize (Lamb, 2010; Wang & Swerdloff, 2014) . Tests of sperm function would therefore have enormous clinical impact in helping physicians counsel couples to the most appropriate form of assisted reproduction; indeed, the development of assays of sperm fertilizing ability are a recognized priority (Lamb, 2010; Oehninger, Franken, & Ombelet, 2014; Wang & Swerdloff, 2014) .
Although freshly ejaculated spermatozoa appear morphologically mature and motile, they are fertilization incompetent until they undergo a maturational process known as "capacitation" (Austin, 1952; Chang, 1951) . In most species, capacitation is dependent on the removal of sterols from the sperm plasma membrane (sterol efflux) and the influx of bicarbonate and calcium ions (Baldi et al., 1991;  Bedu-Addo, Lefièvre, Moseley, Barratt, & Publicover, 2005; Cohen et al., 2014; Gadella & Van Gestel, 2004) . The efflux of sterols that occurs during sperm capacitation changes membrane fluidity, allowing for the redistribution of specific membrane components (Cohen et al., 2014; Cross, 1998; Selvaraj et al., 2007 Selvaraj et al., , 2009 ).
The Cap-Score™ Sperm Function Test (Cap-Score) is an in vitro, laboratory-developed test designed to assess sperm function, particularly regarding capacitation. This assay detects and analyzes the localization patterns of the ganglioside G M1 to evaluate the fertilizing ability of sperm. Conducting a Cap-Score test involves the incubation of sperm in non-capacitating (Non-Cap) medium and medium containing capacitating stimuli (Cap). The sperm that respond to the capacitation stimuli are identified by specific G M1 localization patterns. The final readout-the "Cap-Score"-reports the proportion of sperm within a sample that display the localization patterns that correspond with capacitation.
Validation of diagnostic assays involves multiple steps, typically measuring assay precision, reproducibility, and accuracy (Cleophas & Zwinderman, 2012) . "Accuracy" is used in different ways, including for demonstration of "fit for purpose," demonstration that the assay quantifies its intended target, and demonstration of statistical accuracy or quantification within an acceptable range of uncertainty.
The process of validating an assay without precedent (such as the CapScore) is more complex than for an assay that simply alters the methodology of an established "gold standard" test: an assay of a novel biomarker must be reproducible and precise within samples and between readers. Other endpoints or markers of capacitation must also be used to support the underlying assertion-in this case, that the "capacitated" G M1 localization pattern is actually identifying a capacitated sperm. Finally, clinical and population data are required to show that the capacitation status provides information on male fertility ("fit for purpose").
Relevant to the question of whether or not the Cap-Score assay provides information on male fertility, it is important to note that G M1 localization patterns have been tested in an independent, post hoc clinical trial using a combination of retrospective and prospective medical histories analyzed after performing the assay . In that study, Cap-Scores over a certain threshold were highly correlated with successful fertilization by natural conception or within three or fewer cycles of intrauterine insemination, and Cap-Scores below that threshold were correlated with low fertilization success . Because that trial was performed with a highly skewed patient population consistent with a tertiary care fertility clinic, cohort comparison data were also collected, comparing the distribution of Cap-Scores in a population of men with known fertility versus those questioning their fertility. Significantly more men questioning their fertility had Cap-Scores at or below one standard deviation below the normal mean . Together, the data from those studies demonstrate the fitness of the test for its intended purpose. Indeed, capacitation status is reflected by the CapScore using the ultimate endpoint or criterion of capacitation-the acquisition of fertilizing ability. However, one needs to interrogate those specific cells with other methods to look at capacitation status to prove that the individual sperm with "capacitated" patterns are actually capacitated.
During capacitation, the plasma membrane and outer acrosomal membranes are reported to communicate, thereby exposing some molecules associated with the acrosome (Asano, Nelson-Harrington, & Travis, 2013; Cohen, Mukai, & Travis, 2016; Jin et al., 2011; Kim & Gerton, 2003; Kim, Foster, Kvasnicka, & Gerton, 2011) . Capacitated sperm are also able to undergo acrosome exocytosis. Here we utilized the established tools of peanut agglutinin (PNA), a lectin that binds specific carbohydrate residues associated with the acrosome (Mortimer, Curtis, & Miller, 1987; Vázquez et al., 1996) , and calcium ionophore (A23187), which causes calcium influx into sperm and induces acrosome exocytosis. Use of these or similar reagents can provide mutually reinforcing evidence of the capacitation status of sperm, and allow us to correlate these states to specific patterns of G M1 localization. For example, we previously showed that murine sperm exhibiting a specific pattern of G M1 localization were the same population that underwent acrosome exocytosis, confirming that the pattern in question reflected the capacitation status of those cells (Selvaraj et al., 2007) .
Assay reproducibility and precision pose special problems when dealing with the highly heterogeneous populations of human sperm.
The World Health Organization has published multiple guidelines to reduce subjectivity in evaluations of male fertility and standardize routine semen analysis (World Health Organization, 1999 . Nonetheless, differences still exist within and among individual andrologists (Auger et al., 2000) , raising the question of whether observed differences in semen quality are real or simply reflect modifications in processing or measurement methods (Knuth, Neuwinger, & Nieschlag, 1989) . To improve the identification and treatment of male fertility, semen quality evaluations should demonstrate minimal variation both within single samples and when read by different individuals. This attribute is known as "precision," which refers to how well a given measurement can be reproduced when applied repeatedly to multiple aliquots of a single homogeneous sample (Burd, 2010) . Changes in precision (also referred to as random analytical error) result entirely from factors that may vary during normal operation of an assay. Larger sample sizes often lead to increased precision, particularly when estimating unknown parameters. For example, to estimate the proportion of sperm having intact acrosomes within an ejaculate, a more precise
estimate is obtained when 100 rather than 50 cells are sampled.
However, at some point sampling additional cells results in diminishing returns and constitutes an unnecessary investment of time.
Handling techniques, such as semen liquefaction, must also be considered to ensure that differences in cell preparation that could cause changes in the assay readout are avoided. According to the World Health Organization guidelines, most semen samples should liquefy on their own within 15 min at room temperature. However, samples can be liquefied for up to 60 min at 37°C. And, if samples are not liquefied after 60 min, liquefaction may be induced by: (i) diluting the sample (1:1) with medium; (ii) repeatedly passing the sample through an 18 or 19 gauge needle or pipette (mechanical liquefaction); or (iii) treating the samples with enzymes such as chymotrypsin or bromelain (Mortimer, 1994; World Health Organization, 2010) .
Interestingly, certain liquefaction treatments affect seminal plasma biochemistry and semen parameters (World Health Organization, 2010) . For example, increasing liquefaction time can decrease progressive motility in sperm (Mortimer, Swan, & Mortimer, 1998; Shao et al., 2010) and increase DNA fragmentation (Balasuriya, Serhal, Doshi, & Harper, 2012) . Increases in sperm DNA fragmentation were also observed when mechanical liquefaction is performed with 18-gauge needles (Kussler et al., 2014) .
Enzymatic liquefaction of semen is an alternative to extended time or mechanical methods. Chymotrypsin is a proteolytic enzyme that cleaves amide bonds alongside hydrophobic amino acids (tyrosine, tryptophan, phenylalanine), and is commonly used to treat hyperviscous semen samples (Mortimer, 1994) . Non-viscous and viscous specimens exposed to chymotrypsin have shown little if any change in total motility, forward progression motility, concentration, pH, or volume, but do exhibit a slight change in sperm motility patterns . Increased levels of α-glucosidase activity, a biomarker that is positively correlated with semen quality (Said, Galeraud-Denis, Carreau, & Saad, 2009; Zöpfgen et al., 2000) , are also observed following liquefaction with chymotrypsin , further supporting the minimal impact of chymotrypsin on semen quality. Bromelain, a thiol proteolytic enzyme found in the stem of pineapples, has also been used to treat viscous seminal plasma from dromedary camels, and did not affect sperm motility (Monaco et al., 2016) . This enzyme also has anti-inflammatory, anti-thrombotic, and anti-metastatic properties (Chobotova, Vernallis, & Majid, 2010; Maurer, 2001; Metzig, Grabowska, Eckert, Rehse, & Maurer, 1999; Taussig & Batkin, 1988 ). Yet, very little research has focused on bromelain and its effect on human seminal parameters, such as morphology, sperm count, or sperm function, although it is being investigated/used anecdotally to treat hyperviscosity.
The present study provides a series of experiments that contribute to assay validation for the Cap-Score. First, cell biological experiments were performed to demonstrate assay accuracy. Large image files were generated, and two different readers were trained to determine Cap-Score. The data generated were analyzed to evaluate Cap-Score precision and its variation when determined by the same and different operators. In addition, the Cap-Score was utilized to determine if the length of time of liquefaction, mechanical liquefaction, and enzymatic liquefaction affect capacitation.
| RESULTS

| Accuracy
The Cap-Score detects and analyzes localization patterns of the ganglioside G M1 , which differ in sperm that respond to stimuli for capacitation. Typical G M1 localization patterns in sperm that either have responded to stimuli for capacitation (G M1 /CP), or have either not been exposed to-or have not responded to-such stimuli (G M1 /NCP) are shown (Figure 1a,b) . Because human sperm are so heterogeneous, with many abnormal cells, a great many patterns can be seen beyond these two; one such example is shown in Figure 1b . However, we focused on the two patterns that are the keys for scoring.
Although the G M1 /CP pattern reproducibly appeared in sperm from different fertile men following exposure to stimuli for capacitation, and was correlated with clinical fertility (Selvaraj et al., 2007) . Sperm incubated in basal (Non-Cap) medium only, and then treated with A23187, showed no change in Cap-Score (Figure 2c,d) , supporting the notion that only capacitated cells are capable of acrosome exocytosis.
| Precision
Precision is defined as the repeatability or reproducibility of a measurement performed on the same sample (JCGM/WG2, 2008; Taylor & Cohen, 1998) . The first step in determining Cap-Score precision was to define the number of cells to count per sample. In general, as the number of cells counted increases, there is an increase in precision, up to a point when the Cap-Score will not change appreciably with additional observations. We defined this threshold by measuring the percent change in Cap-Score when 50, 100, 150, and 200 sperm were evaluated. The percent change was large when counting 50 versus 100 sperm compared to counting 100 versus 150 and 150 versus 200 sperm (Table 1) . Thus, Cap-Score precision was only modestly improved by counting more than 100 sperm; however, the 95% confidence intervals for the percent change when counting 50 versus 100 and 150 versus 200 did not overlap, suggesting a significant reduction in percent change when at least 150 cells were counted. A conservative Cap-Score value was therefore determined by counting the G M1 localization patterns of at least 150 cells.
| Statistical accuracy and reproducibility within a sample
Statistical accuracy can be defined as the proximity of measurements to the true value. The true value of an unknown population can be estimated by its central tendency, or the mean. One can judge whether a dataset has a strong or a weak central tendency based on its dispersion, or the inverse of precision (JCGM/WG2, 2008) . The standard deviation and coefficient of variation (coefficient of variation = standard deviation/mean) measure the amount of dispersion within a sample.
Prior to evaluating Cap-Score accuracy by the same reader, we estimated the number of images for each reader to sample. Two semen donor groups were defined based on a cut-off of 1 standard deviation below the mean Cap-Score for a population of men with presumed fertility (pregnant wife or child less than 3 years old). The mean Cap-Score for the group with "lower Cap-Scores" was 27 and the "presumed fertile" group was 40. The standard deviations for each group were 5.2 and 4.9, respectively. A power analysis using a twotailed test was done at the p < 0.05 and p < 0.01 levels, with a probability FIGURE 1 Relationship between G M1 localization patterns, capacitation status, and exposure of acrosomal carbohydrates as detected with PNA. (a) Fluorescence microscopy images (top row) and diagrams (bottom row) of typical human sperm that have not been exposed to, or not responded to, stimuli for capacitation (G M1 /NCP) (left column) or the G M1 distribution typical for cells that have responded to stimuli for capacitation (G M1 /CP) (right column). (b) Representative images of G M1 /NCP patterns predominantly found in sperm incubated under noncapacitating conditions; G M1 /CP pattern that increased in response to incubation with stimuli for capacitation; and a pattern of G M1 localization that appeared infrequently (OTHER). Three patterns of PNA labeling were commonly seen in cells labeled with CTB: no labeling of PNA (None), labeling over the equatorial region (EQ); and labeling over the acrosome (ACR). (c and d) G M1 localization was compared to PNA labeling in sperm incubated under Non-Cap (n = 10) and Cap (n = 10) conditions. Black, gray, and white bars represent the proportion of cells with a given CTB labeling pattern having ACR, EQ, and None PNA label, respectively. Means within a given pattern of G M1 localization were compared. Those means with different superscripts were found to be different using Fisher's LSD (p < 0.05). In general, the majority of sperm with the G M1 /NCP pattern did not label with PNA in both treatment conditions. In contrast, sperm with the G M1 /CP pattern predominantly showed PNA labeling over the acrosome
| 411 of detecting a difference this large, if it exists, of 90%
(1-beta = 0.90). These analyses indicated that, respectively, 10 and 14 images should be sampled (five and seven per group). We therefore generated 10 images each in the "lower Cap-Score" and "presumed fertile" groups to ensure that each was sufficiently interrogated to identify any differences in reproducibility that might occur because of either low-or high-value Cap-Scores. Two different readers determined Cap-Scores by randomly resampling the 10 images each from the "lower Cap-Score" and "presumed fertile" groups 20 times. The average standard deviation across images and readers was 3 while the average coefficient of variation was 13% (Figure 3a ). Both the standard deviation and coefficient of variation showed a linear relationship to Cap-Score, as determined by linear regression. Thus, while there was greater dispersion associated with reading higher Cap-Scores, it appeared to result from a greater Cap-Score magnitude. These data were consistent with a high degree of statistical accuracy because Cap-Score values were clustered tightly about the true value when the same sperm population was randomly resampled by the same or a different reader. 
| Bromelain
A pilot study was performed using the enzyme bromelain to determine 
| DISCUSSION
The results presented here validate the accuracy, repeatability, and precision of the Cap-Score Sperm Function Test; they also provide important information on the influence of semen handling/preparation methods on assay outcomes. This report does not provide the routine protocols for validation of the laboratory methodology to perform the assay, which is beyond the scope of this work.
We investigated if the assay accurately identified sperm that responded to stimuli for capacitation from those that either were not exposed, or did not respond. We used two different approaches pattern is localized over the rostral sperm head, we hypothesized that acrosome exocytosis would result in loss of the membranes contributing to that pattern, and hence either no labeling with CTB or the appearance of cells having an "other" pattern that is consistent with membrane perturbation; both outcomes would lower the Cap-Score, which was observed.
Next, we showed that the precision of this assay was only modestly improved by counting more than 100 sperm, which provides a threshold to ensure that the number of sperm evaluated for each assay was representative of the ejaculate's distribution. Despite the relatively low number required, we chose to score the G M1 localization pattern of at least 150 sperm to be conservative.
The consistency of assay readout among different andrologists was addressed by training two individuals to read G M1 patterns, and then assessing the distribution of their Cap-Score readings.
Twenty large-image files that contained up to 5,000 sperm each were created and resampled 20 times by each reader. An average standard deviation and average coefficient of variation revealed that the assay variance and/or dispersion were small and stable, which is indicative of a high degree of Cap-Score reproducibility per reader. Comparison of the scoring between the two readers showed an average difference of 1 in mean Cap-Score. When the Bonferroni correction was applied, no discernable differences were observed. Similarly, Cap-Score variances were not different Collectively, these comparisons demonstrate that the Cap-Score is highly reproducible and reliable within and between trained readers, which are key considerations when attempting to evaluate male reproductive fitness.
Another source of variance that could affect assay reliability lies in semen handling/preparation and processing techniques. We focused on three main liquefaction approaches, as sperm are sensitive to this step of handling and there is significant variation among andrologists in liquefaction methods. The time allowed for liquefaction in assisted reproduction clinics typically ranges from 0.25 to 1 hr, at 37°C in air or CO 2 incubators. In the present study, liquefaction durations of up to 2 hr did not change Cap-Score, whereas motility was reduced in post-wash samples liquefied for 2 hr. This effect might be a consequence of extended sperm exposure to proteins found in seminal plasma that inhibit motility, such as semenogelin I (Lilja, Abrahamsson, & Lundwall, 1989; Robert & Gagnon, 1999) or its binding partner EPPIN (Silva, Hamil, & O'Rand, 2013) . Prolonged exposure to motility-inhibiting proteins might also affect the ability to separate such inhibitory proteins from sperm by washing.
Mechanical liquefaction with glass Pasteur pipettes or plastic wide-orifice transfer pipettes did not affect capacitation, although use of Pasteur pipettes did result in a decline in post-wash motility. This effect could be a result of differences in expulsion properties between glass and plastic (e.g., stickiness) or in orifice diameter, which influences physical stress (e.g., shear forces). Physical stressors, such as centrifugation and repeated pipetting, were reported to damage rodent and human sperm and to interfere with their motility (Alvarez et al., 1993; Katkov & Mazur, 1998; Varisli, Uguz, Agca, & Agca, 2009 ).
Interestingly, some physical stressors lead to sublethal damage in human sperm that is only observed during extended incubations (Alvarez et al., 1993) . Thus it is possible that damage induced by Pasteur pipettes rendered these sperm less able to withstand sample washing or to survive the subsequent incubation. Nonetheless, our data support the view that the functional impacts were minimal, as Robert & Gagnon, 1999) or its binding partner EPPIN (Silva et al., 2013) . Targeted research beyond the scope of this report would be needed to identify chymotrypsin's specific effects on membrane channels, cAMP activity, and/or tyrosine phosphorylation.
Assessment of male fertility is plagued by the inability to assess sperm function-namely, the ability of a individual's sperm to fertilize an egg (Oehninger et al., 2014; Wang & Swerdloff, 2014) . A simple diagnostic assay would provide a needed functional complement to the descriptive assessments of traditional semen evaluations (World Health Organization, 2010) . Identifying sperm with deficiencies in fertilizing ability will allow for a more specific understanding of what is now categorized as "idiopathic infertility." Of much greater practical importance, such a physiological assessment would enable a clinician to effectively counsel a couple toward the most appropriate form of assisted reproduction to achieve pregnancy. To meet this pressing clinical need, many assays of sperm function have been suggested-e.g., hamster zona pellucida-penetration assays (Barros, Gonzalez, Herrera, & Bustos-Obregon, 1979; Rogers et al., 1979) , sperm-zona pellucidabinding tests (Liu, Garrett, & Baker, 2004) , and cervical mucus penetration assays (Alexander, 1981 ; Eggert-Kruse, Leinhos, Gerhard,
Tilgen , & Runnebaum, 1989; Menge & Beitner, 1989 )-but their use in the clinic is limited by the difficulty in obtaining needed materials in a logistically practical fashion. Filling the current void, data presented here validate the Cap-Score as an assay that can determine the ability of sperm to undergo the physiological changes required to fertilize an egg.
Complementing these findings, the clinical utility of the Cap-Score assay was also tested in an independent, post-hoc clinical trial, in which it was found that capacitation status strongly tracked with a man's history of fertility .
Even when standardized according to the recommendations of national or international organizations, the methods traditionally used for semen analysis remain subjective and variable (Auger et al., 2000; Jørgensen et al., 2001) . Therefore, it has been recommended that internal and external quality controls be developed and the variations observed within and between persons performing semen analysis be evaluated to reduce confounding the assessment of semen quality (Cooper, Neuwinger, Bahrs, & Nieschlag, 1992; Matson, 1995; Mortimer, Shu, & Tan, 1986; Neuwinger, Behre, & Nieschlag, 1990) . In contrast, the data presented in the current study 
| MATERIALS AND METHODS
| Specimen collection
All procedures were approved by the Western Institutional Review Board (https://www.wirb.com/Pages/Default.aspx; Protocol #20152233). Semen samples were collected by manual masturbation from consenting men with known fertility (evidence of fathering a child within the past 3 years or current pregnancy), after a minimum of 2 and a maximum of 5 days of sexual abstinence. Any samples having fewer than 10 × 10 6 motile sperm were discarded from this study.
| Standard sample processing
Ejaculates within a sealed specimen container (Fisher Scientific, 14-375-462) were liquefied at 37°C in an air incubator, and then removed from the seminal plasma by centrifugation through (Osheroff et al., 1999; Parinaud, Vieitez, Vieu, Collet, & Perret, 2000) . Pilot studies showed that this stimulus was as effective in promoting capacitation in human sperm, as measured by G M1 localization patterns, at 3 hr of incubation as albumin was at 6 hr (Vairo et al., 2013) . Following incubation, all samples were fixed with paraformaldehyde (Electron Microscopy Sciences; Hatfield, PA), as previously described (Selvaraj et al., 2006) . The fixed samples were maintained at room temperature overnight prior to labeling.
| Cap-Score and acrosome exocytosis
Two treatments were prepared for each of 10 semen samples. Cap and Non-Cap treatments were incubated, respectively, with and without 2-hydroxypropyl-β-cyclodextrin for 3 hr. For seven of these samples, a third treatment, Cap + ionophore, was prepared in which sperm were incubated with 2-hydroxypropyl-β-cyclodextrin for 2.75 hr, then the calcium ionophore A23187 (Sigma-Aldrich, Allentown, PA; reference C7522) was added to a final concentration of 20 μM and the cells were incubated for another 0.25 hr.
In a second set of experiments, Cap (n = 4) and Non-Cap (n = 5) treatments were incubated, respectively, with and without 2-hydroxypropyl-β-cyclodextrin for 3 hr, plus a third treatment of Non-Cap + ionophore was prepared. For this treatment, sperm were incubated in basal non-capacitating media for 2.75 hr, then the calcium ionophore A23187 (Sigma-Aldrich) was added to a final concentration of 20 μM and the cells were incubated for another 0.25 hr.
Following incubation, the sperm were attached to slides for 0.25 hr, labeled for 10 min with 10 μg/ml of Alexa Fluor ® 647-conjugated PNA from Arachis hypogaea (Thermo Fisher, Allentown, PA; reference L32460), washed 1× with mHTF, fixed for 0.5 hr, and then labeled with 2 μg/ml of Alexa Fluor 488-conjugated CTB (Thermo Fisher, reference C34775). All labeling and slide work was done in a humidified chamber maintained at 37°C.
| Calculating sperm motility
The percentage of motile sperm was evaluated by counting non-motile and motile sperm in 10 squares on a Makler chamber (Sefi-Medical Instruments; Haifa, Israel), and then the number of motile sperm was divided by the total number of sperm counted.
Motility was determined four separate times for each treatment.
This was achieved by having two unique samples of the treatment assessed by two different readers. The average of the four motility readings was recorded after liquefaction (initial), after standard processing (post-wash), and after the 3-hr incubation (postincubation).
| Varying time of liquefaction
Ejaculates of 10 fertile individuals were split into two portions. The first portion was liquefied for 0.25 hr while the second portion was liquefied for 1.25 hr in a sealed 15-ml polypropylene conical tube (FALCON; reference 352096) placed in a 37°C water bath. In later experiments, nine ejaculates were liquefied for 0.25 and 2 hr. All tests of liquefaction duration were performed at 37°C.
| Mechanical liquefaction
Five samples from four fertile men were split into three portions. 
| Liquefaction with chymotrypsin
Samples from five fertile men were split into three portions. The first portion was liquefied following standard processing methods (control); the second portion was liquefied with chymotrypsin (VitroLife; reference 15524) according to the manufacturer's direction, using a fixed 5 mg/ejaculate for 0.25 hr; and the third portion was liquefied following standard processing methods, but was incubated for 3 hr in the presence of 3 mg/ml chymotrypsin.
| Liquefaction with bromelain
Samples from five fertile men were split into two portions. The first portion was liquefied for 0.25 hr at 37°C; and the second portion was liquefied with bromelain (Sigma; reference B5144-100UN), as recommended by the World Health Organization (2010), for 0.25 hr at 37°C (10 units/ml). Both portions were then processed following standard operating procedures.
| Sample labeling
Following incubation and fixation, liquefied samples were labeled with 2 μg/ml of Alexa Fluor 488-conjugated CTB. After 10 min, 5 μl of the labeled sperm was placed on a microscope slide, overlaid with a cover slip, and moved to an imaging station. 
| Statistical analyses
Power Analysis was done using G*power (Faul, Erdfelder, Lang, & Buchner, 2007) . The following four quantities have an intimate relationship: (i) sample size; (ii) effect size; (iii) significance level = probability (Type I error) = incorrect rejection of a true null hypothesis (a "false positive"); and (iv) power = 1 − probability (Type II error) = incorrectly retaining a false null hypothesis ("false negative").
Given any three, the fourth can be determined. For the purposes of this study, power analysis was used to estimate the number of images to sample for evaluating Cap-Score accuracy.
Student's t-test was performed using Microsoft Excel (2013), and was used to compare Cap-Score means between two readers. In this example 20 different means were compared, increasing the chance of incorrectly rejecting the null hypothesis that there is no difference between the means (i.e., making a Type I error). A Bonferroni correction was applied to counteract this problem. Similarly, Student's t-test was used to compare the Cap-Scores for liquefaction timing, mechanical liquefaction, and enzymatic liquefaction using the online statistical calculator in silico (t-test; available online at: http://in-silico.
net/tools/statistics/ttest). calculated for enzymatic liquefaction motilities by using XLSTAT (Version 2015.6.01.25740) .
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